ERBB2 and breast carcinoma: This mouse model is a faithful model of spontaneous mammary gland carcinogenesis due to overexpression of the ErbB2/neu proto-oncogene and has been previously used to test the efficacy of drug therapies for breast cancer [16], [17], [18].